The fate of the drugs identified in the inspeciton inspectio
By Lee, Tak-Sun | translator Kim, Jung-Ju
23.10.13 05:50:55
가나다라
0
Parkinson's disease patient complains of side effects from generic drugs after being inspected by the National Assembly
Attention is being paid to whether the drugs that were singled out in the National Assembly Health and Welfare Committee audit will be able to gain new wings based on orders from lawmakers
Enhertu was mentioned by People Power Party lawmaker Kang Ki-yoon. He said that the number of female cancer patients is rapidly increasing and ordered coverage of expensive innovative treatments. At this point, Enhertu appeared. He said, “It costs about 150 million won to cure breast cancer with Enhertu,” and asked for prompt payment, saying, “Many unfortunate cases are occurring due to lack of money.”
Enhertu is currently tied up in HIRA. After a retrial last May, the Cancer Disease Review Committee established the benefit standards, but the Pharmaceutical Re
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)